New Study Explores Role of Vitamin D in Preventing Diabetes Among At-Risk Groups

What if a simple vitamin could help stop diabetes-if your genes are on your side?

A new study published in JAMA Network Open suggests that vitamin D may help delay or prevent the progression from prediabetes to type 2 diabetes—but only in people with specific genetic variations. The findings highlight a growing shift toward personalized medicine, where treatments are tailored to an individual’s biology rather than applied universally.

Researchers analyzed data from the large D2d clinical trial, which tested whether a daily high dose of vitamin D (4,000 IU) could reduce diabetes risk in over 2,000 U.S. adults with prediabetes. While the original trial showed no overall benefit, a deeper genetic analysis revealed a more nuanced picture.

The key lies in the Vitamin D receptor gene, which helps the body respond to vitamin D. Participants with certain variations of this gene—specifically the AC or CC types—experienced a 19% lower risk of developing diabetes when taking vitamin D supplements. In contrast, those with the AA variation, about 30% of participants, saw no benefit at all.

This difference may be linked to how vitamin D interacts with the pancreas. The vitamin binds to receptors in insulin-producing cells, potentially improving insulin release and blood sugar control. But if the receptor functions differently due to genetics, the effect may be reduced or absent.

Experts say these findings could eventually lead to simple genetic tests that identify who might benefit most from vitamin D supplementation. However, they also caution against self-prescribing high doses. Current guidelines recommend much lower daily amounts, and excessive intake can cause harm, including increased risk of falls and fractures.

While more research is needed, the study offers an important insight: preventing diabetes may not be one-size-fits-all. Instead, the future could lie in targeted, personalized strategies—where even a common vitamin becomes a precision tool for better health.

REFERENCE: Dawson-Hughes, B., et al. (2026). Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes. JAMA Network Open. DOI: 10.1001/jamanetworkopen.2026.7332. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2848109